Cargando…
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
The immune response to SARS-CoV-2 is critical in controlling disease but there is concern that waning immunity may predispose to re-infection. We analysed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at six months following infection. T-cell responses were pre...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610739/ https://www.ncbi.nlm.nih.gov/pubmed/33674800 http://dx.doi.org/10.1038/s41590-021-00902-8 |
_version_ | 1783605226688741376 |
---|---|
author | Zuo, Jianmin Dowell, Alexander C. Pearce, Hayden Verma, Kriti Long, Heather M. Begum, Jusnara Aiano, Felicity Amin-Chowdhury, Zahin Hallis, Bassam Stapley, Lorrain Borrow, Ray Linley, Ezra Ahmad, Shazaad Parker, Ben Horsley, Alex Amirthalingam, Gayatri Brown, Kevin Ramsay, Mary E. Ladhani, Shamez Moss, Paul |
author_facet | Zuo, Jianmin Dowell, Alexander C. Pearce, Hayden Verma, Kriti Long, Heather M. Begum, Jusnara Aiano, Felicity Amin-Chowdhury, Zahin Hallis, Bassam Stapley, Lorrain Borrow, Ray Linley, Ezra Ahmad, Shazaad Parker, Ben Horsley, Alex Amirthalingam, Gayatri Brown, Kevin Ramsay, Mary E. Ladhani, Shamez Moss, Paul |
author_sort | Zuo, Jianmin |
collection | PubMed |
description | The immune response to SARS-CoV-2 is critical in controlling disease but there is concern that waning immunity may predispose to re-infection. We analysed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at six months following infection. T-cell responses were present by ELISPOT and/or ICS analysis in all donors and characterised by predominant CD4+ T cell responses with strong IL-2 cytokine expression. Median T-cell responses were 50% higher in donors who had experienced a symptomatic infection indicating that the severity of primary infection establishes a ‘setpoint’ for cellular immunity. T-cell responses to spike and nucleoprotein/membrane proteins were correlated with peak antibody levels. Furthermore, higher levels of nucleoprotein-specific T cells were associated with preservation of NP-specific antibody level although no such correlation was observed in relation to spike-specific responses. In conclusion, our data are reassuring that functional SARS-CoV-2-specific T-cell responses are retained at six months following infection. |
format | Online Article Text |
id | pubmed-7610739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-76107392021-09-05 Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection Zuo, Jianmin Dowell, Alexander C. Pearce, Hayden Verma, Kriti Long, Heather M. Begum, Jusnara Aiano, Felicity Amin-Chowdhury, Zahin Hallis, Bassam Stapley, Lorrain Borrow, Ray Linley, Ezra Ahmad, Shazaad Parker, Ben Horsley, Alex Amirthalingam, Gayatri Brown, Kevin Ramsay, Mary E. Ladhani, Shamez Moss, Paul Nat Immunol Article The immune response to SARS-CoV-2 is critical in controlling disease but there is concern that waning immunity may predispose to re-infection. We analysed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at six months following infection. T-cell responses were present by ELISPOT and/or ICS analysis in all donors and characterised by predominant CD4+ T cell responses with strong IL-2 cytokine expression. Median T-cell responses were 50% higher in donors who had experienced a symptomatic infection indicating that the severity of primary infection establishes a ‘setpoint’ for cellular immunity. T-cell responses to spike and nucleoprotein/membrane proteins were correlated with peak antibody levels. Furthermore, higher levels of nucleoprotein-specific T cells were associated with preservation of NP-specific antibody level although no such correlation was observed in relation to spike-specific responses. In conclusion, our data are reassuring that functional SARS-CoV-2-specific T-cell responses are retained at six months following infection. 2021-05-01 2021-03-05 /pmc/articles/PMC7610739/ /pubmed/33674800 http://dx.doi.org/10.1038/s41590-021-00902-8 Text en http://www.nature.com/authors/editorial_policies/license.html#termsUsers may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Zuo, Jianmin Dowell, Alexander C. Pearce, Hayden Verma, Kriti Long, Heather M. Begum, Jusnara Aiano, Felicity Amin-Chowdhury, Zahin Hallis, Bassam Stapley, Lorrain Borrow, Ray Linley, Ezra Ahmad, Shazaad Parker, Ben Horsley, Alex Amirthalingam, Gayatri Brown, Kevin Ramsay, Mary E. Ladhani, Shamez Moss, Paul Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection |
title | Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection |
title_full | Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection |
title_fullStr | Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection |
title_full_unstemmed | Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection |
title_short | Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection |
title_sort | robust sars-cov-2-specific t-cell immunity is maintained at 6 months following primary infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610739/ https://www.ncbi.nlm.nih.gov/pubmed/33674800 http://dx.doi.org/10.1038/s41590-021-00902-8 |
work_keys_str_mv | AT zuojianmin robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT dowellalexanderc robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT pearcehayden robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT vermakriti robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT longheatherm robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT begumjusnara robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT aianofelicity robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT aminchowdhuryzahin robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT hallisbassam robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT stapleylorrain robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT borrowray robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT linleyezra robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT ahmadshazaad robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT parkerben robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT horsleyalex robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT amirthalingamgayatri robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT brownkevin robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT ramsaymarye robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT ladhanishamez robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection AT mosspaul robustsarscov2specifictcellimmunityismaintainedat6monthsfollowingprimaryinfection |